Cost-benefit analysis set for Advate, hemophilia A treatment

December 21, 2020
Hemophilia News Today

Related news

In the news

February 16, 2023

60+ healthcare companies on Forbes’ list of best employers

Becker’s Hospital Review

In the news

December 19, 2022

How to Ascend in Your Career (With Erin Feigal)

People Make it Possible podcast

In the news

December 16, 2022

Prime Therapeutics joins other PBMs in adding Humira biosimilars

Becker’s Payer Issues